ABOUT US

Open Mind Therapeutics Logo Mark

At Open Mind Therapeutics, we conduct research on psychedelic medicines and advise organizations engaging in projects that involve them. Our mission is to participate in the continued understanding of psychedelic medicines through clinical research and to support organizations seeking to positively impact their communities through the informed, attuned use of these powerful tools.

Meet Our Team

The Open Mind Therapeutics team was brought together through the shared desire to participate in society’s continued exploration of psychedelic medicines as instruments of healing. While we come from a diverse set of backgrounds – physicians, therapists, researchers, start-up founders, and organizational leaders – we are united in the belief that the current Western mental health treatment paradigm is woefully inadequate, and that psychedelic medicines very likely offer part of the necessary change we all want to see.

Sidney Edsall, MD, Chief Executive Officer of Open Mind Therapeutics

Sidney Edsall, MD

Chief Executive Officer

Dr Sylvestre Quevedo

Sylvestre Quevedo, MD

Chief Medical Officer

Charlie Bathgate, Chief Operating Officer of Open Mind Therapeutics

Charlie Bathgate

Chief Operating Officer

Phillip Perl of Open Mind Therapeutics

Phillip Perl

Research Director

Vignesh Ravichandran

Vignesh Ravichandran

CLINICAL RESEARCH

Cybin Study Team

The Cybin psilocin research trial team brings together psychiatrists, psychologists, physicians, and nurse practitioners with experience in psychedelic-assisted therapy, integrative psychiatry, and clinical research. United by a focus on safety, compassion, and scientific rigor, they guide participants through every stage of the study.

Dr. Patricia Pop, MD

Dr. Patricia Pop, MD

Session Monitor

Dr. Devon Cortight, Psy.D

Dr. Devon Cortight, Psy.D

Session Monitor

Dr. Audrey Redfield, PhD

Dr. Audrey Redfield, PhD

Session Monitor

Dr. Jennifer Firepine, MD

Dr. Jennifer Firepine, MD

Clinical Rater

Dr. Gianni Glick, MD

Dr. Gianni Glick, MD

Session Monitor

Dr. Christophe Gimmler, MD, LMFT

Dr. Christophe Gimmler, MD, LMFT

Study Physician

Diane Kim, PMHNP-BC

Diane Kim, PMHNP-BC

Clinical Rater

Amanda Kelly, NP/PA

Amanda Kelly, NP/PA

Nurse / Physician Assistant

Dr. Sharon Meyer, MD

Dr. Sharon Meyer, MD

Study Physician

Sean Luong

Sean Luong

Study Nurse

Frequently Asked Questions

Is Open Mind Therapeutics related to Open Mind Collective?

Open Mind Therapeutics and Open Mind Collective are sister organizations. While they are separate legal entities – Open Mind Collective is a 501c3 non-profit organization and Open Mind Therapeutics is a California-based LLC – they share many of the same guiding principles, and certain team members work for both.

Is Open Mind Therapeutics open to engaging in new clinical trials?

For the time being, yes, our team is evaluating participation in new clinical trials. If you represent a trial sponsor or are otherwise involved a new trial you think we may be able to help with, please email Sidney.

Does Open Mind Therapeutics offer direct clinical services, like ketamine-assisted psychotherapy (KAP)?

No, Open Mind Therapeutics does not offer direct clinical services. If you are interested in therapy, including KAP, please visit the  Quantum Integral Healing Arts website.